Adverse events

Sarcopenia as a predictor of outcome after transcatheter aortic valve implantation: protocol for systematic review and meta-analysis
Kai Luo, Lei Yang, Yu Li

BMJ Open Nov 2022, 12 (11) e067461; DOI: 10.1136/bmjopen-2022-067461
Association of urinary bisphenol A concentrations with in vitro fertilisation outcomes: a systematic review and meta-analysis protocol
Xian-Ling Cao, Nai-Xin Xu, Xuan-You Zhou, Chen-Ming Xu

BMJ Open Nov 2022, 12 (11) e063930; DOI: 10.1136/bmjopen-2022-063930
Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults
Minoo Mohraz, Mohammadreza Salehi, Payam Tabarsi, Mohsen Abbasi-Kangevari, Seyyed-Hadi Ghamari, Erfan Ghasemi, Maryam Amini Pouya, Negar Rezaei, Naser Ahmadi, Kazem Heidari, Mohammad-Reza Malekpour, Mojtaba Nasiri, Ali Akbar Amirzargar, Sahar Saeedi Moghaddam, Bagher Larijani, Hamed Hosseini

BMJ Open Apr 2022, 12 (4) e056872; DOI: 10.1136/bmjopen-2021-056872
Adverse drug events associated with nortriptyline compared with paroxetine and alternative medications in an older adult population: a retrospective cohort study in Southern California
Monique Margaret George, Robert Louis Deamer, Duy Do

BMJ Open Dec 2023, 13 (12) e076028; DOI: 10.1136/bmjopen-2023-076028
Effects of the different intensities of task-oriented training on the upper extremity motor function and self-care ability of stroke survivors: study protocol for a multiarm parallel-group randomised controlled trial in a tertiary hospital in China
Shengfeng Liu, Kai Zhang, Xuecha Li, Chunxiang Li, Mengsi Peng

BMJ Open Dec 2023, 13 (12) e074106; DOI: 10.1136/bmjopen-2023-074106
Effect of whole-body cryotherapy versus placebo cryotherapy on joint pain induced by aromatase inhibitors in women with early stage breast cancer: a randomised clinical trial
Martha Duraes, Marion Garbay, Catherine Ferrer, Claire Duflos, Gauthier Rathat

BMJ Open Dec 2023, 13 (12) e071756; DOI: 10.1136/bmjopen-2023-071756
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials
Ariel Izcovich, Reed Alexander Siemieniuk, Jessica Julia Bartoszko, Long Ge, Dena Zeraatkar, Elena Kum, Anila Qasim, Assem M Khamis, Bram Rochwerg, Thomas Agoritsas, Derek K Chu, Shelley L McLeod, Reem A Mustafa, Per Vandvik, Romina Brignardello-Petersen

BMJ Open Mar 2022, 12 (3) e048502; DOI: 10.1136/bmjopen-2020-048502
AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors
Tadashi Matsushita, Nobuaki Suzuki, Azusa Nagao, Chiai Nagae, Haruko Yamaguchi-Suita, Yui Kyogoku, Akiko Ioka, Keiji Nogami

BMJ Open Mar 2022, 12 (3) e057018; DOI: 10.1136/bmjopen-2021-057018
Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
Lenneke Minjon, Juul W Aarts, Els van den Ban, Toine CG Egberts, Eibert R Heerdink

BMJ Open Mar 2022, 12 (3) e058940; DOI: 10.1136/bmjopen-2021-058940
Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP)
David Ekqvist, Anna Bornefall, Daniel Augustinsson, Martina Sönnerbrandt, Michaela Jonsson Nordvall, Mats Fredrikson, Björn Carlsson, Mårten Sandstedt, Ulrika S H Simonsson, Jan-Willem C Alffenaar, Jakob Paues, Katarina Niward

BMJ Open Mar 2022, 12 (3) e054788; DOI: 10.1136/bmjopen-2021-054788

Main menu

Adverse events

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Adverse events

Pages